Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: journey (112), trip (43), passage (75)

DVd Weekly Daratumumab-Bortezomib-Dexamethasone weekly Cycles 9 onwards

Description: Chemotherapy Protocol Myeloma DVd (weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 9 onwards) Regimen • Myeloma – Bortezomib (weekly) with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-weekly-Cycles-9-onwards.pdf

Ready Steady Go: Ask 3 questions

Description: Ask 3 Questions There may be choices to make about your healthcare. Make sure you get the answers to these three
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Ready-Steady-Go-Ask-3-questions.pdf

NIHR BRC Education and Training Fund first Call Information Sheet

Description: For Biomedical Research Centre (BRC) in association with Southampton Academy of Research (SoAR) Education, Training & Career Development Fund Information on the
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-BRC-Education-and-Training-Fund-first-Call-Information-Sheet.pdf

Ready Steady Go - postcard (print ready)

Description: Ask 3 Questions There may be choices to make about your healthcare. Make sure you get the answers to these three
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/ReadySteadyGo/Printready/Ready-Steady-Go-postcard-print-ready.pdf

NIHR BRC Education and Training Fund Second Call Information Sheet 2020

Description: For Biomedical Research Centre (BRC) in association with Southampton Academy of Research (SoAR) Education, Training and Career Development Fund The BRC
Url: /Media/Southampton-Clinical-Research/SoAR/NIHR-BRC-Education-and-Training-Fund-Second-Call-Information-Sheet-2020.pdf

Recovering from heart surgery - Mindful movement for moving, lifting and physical activity - patient information

Description: This factsheet contains important information about movement, lifting and physical activity while you are recovering from heart surgery.
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Recovering-from-heart-surgery-Mindful-movement-for-moving-lifting-and-physical-activity-3135-PIL.pdf

Post sternotomy activity - patient information

Description: This leaflet provides information recovering from cardiac surgery
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Post-sternotomy-activity-3135-PIL.pdf

Daratumumab

Description: Chemotherapy Protocol Myeloma Daratumumab Regimen • Myeloma – Daratumumab monotherapy Indication • Daratumumab monotherapy is recommended as an option for treating relapsed and refractory
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab.pdf

DVd_Twice weekly_Daratumumab-Bortezomib-Dexamethasone_Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (twice weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (twice weekly)-Daratumumab-Dexamethasone Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Twice-weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (Weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (weekly)-Daratumumab-Dexamethasone Indication • Daratumumab in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

41 to 50 of 212

Previous … 3 4 5 6 7 … Next